Pyrimidine nucleosides. 5. Syntheses of carcinostatic halogenocyclonucleosides.
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D003500:Cyclization; D003561:Cytarabine / Q000138:chemical synthesis / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006219:Halogens; D007939:Leukemia L1210 / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009705:Nucleosides / Q000138:chemical synthesis* / Q000627:therapeutic use; D011743:Pyrimidines / Q000138:chemical synthesis / Q000627:therapeutic use; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D006219:Halogens; D009705:Nucleosides; D011743:Pyrimidines; D003561:Cytarabine